Scientific Sessions 2024  /  AI-enabled Digital Biomarkers for Enhancing Cardiovascular Disease Prediction and Management: A JAMA Session  /  AI biomarkers in the era of multimodality imaging and their role in clinical discovery
Logo

American Heart Association

  2
  0

Final ID:

AI biomarkers in the era of multimodality imaging and their role in clinical discovery

  • Tardif, Jean-claude  ( MONTREAL HEART INSTITUTE , Montreal , Quebec , Canada )
  • Dweck, Marc  ( University of Edinburgh , eDINBURGH , United Kingdom )
    • Author Disclosures:
    Jean-Claude Tardif: DO have relevant financial relationships ; Research Funding (PI or named investigator):Amarin:Past (completed) ; Research Funding (PI or named investigator):Boeringher-Ingelheim:Active (exists now) ; Research Funding (PI or named investigator):Novo-Nordisk:Active (exists now) ; Consultant:DalCor Pharmaceuticals:Active (exists now) ; Ownership Interest:DalCor Pharmaceuticals:Active (exists now) ; Speaker:Pfizer:Active (exists now) ; Speaker:Pendopharm:Past (completed) ; Speaker:HLS Pharmaceuticals:Past (completed) ; Research Funding (PI or named investigator):Pfizer:Active (exists now) ; Research Funding (PI or named investigator):Novartis:Active (exists now) ; Research Funding (PI or named investigator):Merck:Active (exists now) ; Research Funding (PI or named investigator):Esperion:Active (exists now) ; Research Funding (PI or named investigator):DalCor Pharmaceuticals:Active (exists now) ; Research Funding (PI or named investigator):Ceapro:Active (exists now) ; Research Funding (PI or named investigator):AstraZeneca:Past (completed) | marc dweck: DO have relevant financial relationships ; Advisor:Astra Zeneca:Active (exists now) ; Speaker:Bristol Myers Squibb:Active (exists now) ; Speaker:Pfizer:Active (exists now) ; Advisor:Silence Therapeutics:Active (exists now) ; Advisor:novartis:Active (exists now)
Meeting Info:

Scientific Sessions 2024

2024

Chicago, Illinois

Session Info:

AI-enabled Digital Biomarkers for Enhancing Cardiovascular Disease Prediction and Management: A JAMA Session

Sunday, 11/17/2024 , 09:45AM - 11:00AM

Cardiovascular Seminar

More abstracts on this topic:
Regulatory landscape for AI-enabled digital biomarkers: how should we evaluate digital vs traditional biomarkers

Saha Anindita, Tarver Michelle

AI-ECG as a global marker of cardiovascular risk: precision phenotyping across resource settings

Brant Luisa, Svennberg Emma

More abstracts from these authors:
Substantial cardiovascular risk reduction with icosapent ethyl in patients with prior cardiovascular events regardless of coronary artery disease history: REDUCE-IT CAD

Aggarwal Rahul, Tardif Jean-claude, Steg Philippe, Bhatt Deepak, Ballantyne Christie, Miller Michael, Brinton Eliot, Jacobson Terry, Ketchum Steven, Lira Pineda Armando, Doyle Ralph

The Polygenic Mechanisms of Dilated Cardiomyopathy Contribute to The Development of Tachycardia-Associated Cardiomyopathy in Patients With Atrial Tachyarrhythmias

Safabakhsh Sina, Raymond-paquin Alexandre, Jordà Paloma, Grondin Steffany, Parker Jeremy, Fazeli Amir, Castillo Ismael, Laksman Zachary, Tardif Jean-claude, Tadros Rafik

You have to be authorized to contact abstract author. Please, Login
Not Available